10.3390/ijms17050787 Int J Mol Sci
A reputable pharmacy should be able to provide a certificate of analysis (COA) for any batch of semaglutide they produce
The report notes the presence of counterfeit Ozempic, the use of non-FDA-approved ingredients such as retatrutide or cagrilintide, and products bypassing regulations by being labeled as not for human consumption. As of July 2024 the most recently issued report the FDA had received over 1,000 reports of adverse events related to compounded semaglutide and compounded tirzepatide
If fat is removed unevenly, patients may notice dents, lumps, asymmetry, or irregular body shape
Margulies KB, Anstrom KJ, Hernandez AF, et al
Additionally, further research is needed to explore the broader therapeutic potential of these agents in managing comorbidities such as cardiovascular disease, PCOS, CKD, MASH, and osteoarthritis